SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921895-22-000442
Filing Date
2022-02-14
Accepted
2022-02-11 19:41:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO THE SCHEDULE 13G sc13ga207422fbrx_02142022.htm SC 13G/A 262638
  Complete submission text file 0000921895-22-000442.txt   264340
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address 1124 W CARSON STREET MRL BUILDING 3-320 TORRANCE CA 90502
Business Address 1124 W CARSON STREET MRL BUILDING 3-320 TORRANCE CA 90502 (310) 618-6994
Forte Biosciences, Inc. (Subject) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89959 | Film No.: 22623875
SIC: 2834 Pharmaceutical Preparations